Position history for Avoro Capital Advisors LLC's holdings in XENON PHARMACEUTICALS INC
Avoro Capital Advisors LLC holds 5.8M shares of XENE (XENON PHARMACEUTICALS INC), worth $336M as of 2026-Q1. The position was increased (+6.5% shares). XENE represents 3.3% of Avoro Capital Advisors LLC's portfolio.
Current Value
$336M
Current Shares
5.8M
Total Value Change
+$115M
Total Shares Change
+111,111
Other major holders of XENE: UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Increased |
| 5.8M |
+6.5% |
| $336M |
| 3.3% |
| $43.79 |
62 |
| 2025-Q4 | Increased | 5.4M | +0.5% | $243.1M | 2.4% | $44.12 | 54 |
| 2025-Q3 | Unchanged | 5.4M | 0.0% | $216.8M | 2.8% | $39.06 | 0 |
| 2025-Q2 | Decreased | 5.4M | -6.0% | $169M | 3.0% | $32.40 | 0 |
| 2025-Q1 | Increased | 5.7M | +1.3% | $192.6M | 3.0% | $34.26 | 58 |
| 2024-Q4 | Unchanged | 5.7M | 0.0% | $222.1M | 3.1% | $38.53 | 0 |
| 2024-Q3 | Unchanged | 5.7M | 0.0% | $223.1M | 3.3% | $38.65 | 0 |
| 2024-Q2 | Unchanged | 5.7M | 0.0% | $220.9M | 2.9% | $38.99 | 0 |